This supports the hypothesis that early during MG-2477-treatment BECN1 is displaced from BCLXL by increased amounts of cellular NOXA, which triggers autophagy initiation in neuroblastoma cells (Figure 3B). The gene discussed is BECN1; the disease is neuroblastoma.